IVIG-mediated effector functions in autoimmune and inflammatory diseases

Abstract : Intravenous immunoglobulin (IVIG) is a pooled preparation of normal IgG obtained from several thousand healthy donors. It is widely used in the immunotherapy of a large number of autoimmune and inflammatory diseases. The mechanisms of action of IVIG are complex and, as discussed in this review, experimental and clinical data provide an indicator that the therapeutic benefit of IVIG therapy is due to several mutually non-exclusive mechanisms affecting soluble mediators as well as cellular components of the immune system. These mechanisms depend on Fc and/or F(ab′)2 fragments. A better understanding of the effector functions of IVIG should help in identification of biomarkers of responses to IVIG in autoimmune patients.
Type de document :
Article dans une revue
International Immunology, Oxford University Press (OUP), 2017, 29 (11), pp.491-498. 〈10.1093/intimm/dxx039〉
Liste complète des métadonnées

Littérature citée [85 références]  Voir  Masquer  Télécharger

https://hal.sorbonne-universite.fr/hal-01723553
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : jeudi 8 mars 2018 - 10:45:42
Dernière modification le : mardi 4 décembre 2018 - 01:24:14
Document(s) archivé(s) le : samedi 9 juin 2018 - 12:56:41

Fichier

Int Immunol 2017.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry. IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology, Oxford University Press (OUP), 2017, 29 (11), pp.491-498. 〈10.1093/intimm/dxx039〉. 〈hal-01723553〉

Partager

Métriques

Consultations de la notice

98

Téléchargements de fichiers

18